科研级Daclizumab, Anti-IL2RA Recombinant Antibody, Research Grade Daclizumab
Molecular Name
Daclizumab
Size
1mg, 5mg
CAS Number
152923-56-3
Isotype
IgG1 Kappa
Clonality
Monoclonal
Concentration
1mg/ml
Molecular Weight
142.61 kDa
Applications
ELISA, Neut, IF, IP, FC, FuncS, MRI
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Protein Chemical Formula
C6332H9808N1678O1989S42
Target
IL2RA[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Daclizumab (trade name Zinbryta) is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.